No replacement for Enhance Group’s ex-Singapore MD; BNPP AM names new Hong Kong CEO; T Rowe makes two senior appointments in Japan; GAM launches healthcare equity fund in Taiwan; Fidelity’s Eight Roads rolls out China-focused healthcare fund; BNPP AM acquires majority stake in Belgian robo-advisory firm; and more
Look for investors in Asia to increasingly tilt away from their global bond and credit allocations, said Rossen Djounov GAM’s head of Asia.
Harvest launches an ETF in China; Malaysia’s Am Invest rolls out a feeder fund; Schroders completes acquisition of PE firm Adveq; Willis Towers Watson creates APAC financial solutions role; GAM poaches from Schroders for Japan sales role; Newton Investment Management introduces new management structure; and more…
There’s more scope for the right liquid alternatives products in Asia, according to Rossen Djounov, GAM’s new managing director and head of Asia.
This week FSA presents a quick comparison of the GAM Star European Equity Fund and the sector, Europe including UK equities.
FSA compares the Julius Baer Luxury Brands Fund with the Pictet Premium Brands Fund.
Change at Columbia Threadneedle; Movement at SSGA; GAM hires; Vanguard rocks UK; M&G sanity check; Wisdom from AB; Singapore’s mojo; Betting on Trump and much more.
FSA compares the GAM Star China Equity Fund and the JPM China Fund.
The acronym VARP is popping up, led by an increasing interest in Pakistan investment.
FSA compares the GAM Star China Equity Fund and the Blackrock Global Funds China Fund.
Part of the Mark Allen Group.
